1. Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia. (January 2021) Authors: Kishi, Taro; Sakuma, Kenji; Okuya, Makoto; Iwata, Nakao Journal: Journal of psychiatric research Issue: Volume 132(2021) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study. Issue 1 (28th January 2021) Authors: Kishi, Taro; Okuya, Makoto; Sakuma, Kenji; Otaka, Yohei; Saitoh, Eiichi; Iwata, Nakao Journal: Neuropsychopharmacology reports Issue: Volume 41:Issue 1(2021) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials. (August 2019) Authors: Kishi, Taro; Ikuta, Toshikazu; Sakuma, Kenji; Matsuda, Yuki; Iwata, Nakao Journal: Journal of psychiatric research Issue: Volume 115(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Duration of long‐acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia. Issue 7 (1st June 2021) Authors: Kishi, Taro; Sakuma, Kenji; Okuya, Makoto; Hatano, Masakazu; Iwata, Nakao Journal: Psychiatry and clinical neurosciences Issue: Volume 75:Issue 7(2021) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of a conventional mood stabilizer alone or in combination with second‐generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta‐analysis of randomized, placebo‐controlled trials. (26th February 2021) Authors: Kishi, Taro; Sakuma, Kenji; Okuya, Makoto; Matsuda, Yuki; Esumi, Satoru; Hashimoto, Yasuhiko; Hatano, Masakazu; Miyake, Nobumi; Miura, Itaru; Mishima, Kazuo; Iwata, Nakao Journal: Bipolar disorders Issue: Volume 23:Number 8(2021) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan. (June 2021) Authors: Kishi, Taro; Ikuta, Toshikazu; Sakuma, Kenji; Okuya, Makoto; Iwata, Nakao Journal: Journal of psychiatric research Issue: Volume 138(2021) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind, randomized, placebo‐controlled trials with an enrichment design. Issue 3 (26th April 2019) Authors: Oya, Kazuto; Sakuma, Kenji; Esumi, Satoru; Hashimoto, Yasuhiko; Hatano, Masakazu; Matsuda, Yuki; Matsui, Yuki; Miyake, Nobumi; Nomura, Ikuo; Okuya, Makoto; Iwata, Nakao; Kato, Masaki; Hashimoto, Ryota; Mishima, Kazuo; Watanabe, Norio; Kishi, Taro Journal: Neuropsychopharmacology reports Issue: Volume 39:Issue 3(2019) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan. Issue 3 (7th August 2020) Authors: Kishi, Taro; Nosaka, Tadashi; Sakuma, Kenji; Okuya, Makoto; Iwata, Nakao Journal: Neuropsychopharmacology reports Issue: Volume 40:Issue 3(2020) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review. Issue 4 (23rd September 2021) Authors: Kishi, Taro; Nishida, Maika; Koebis, Michinori; Taninaga, Takehiro; Muramoto, Kenzo; Kubota, Naoki; Moline, Margaret; Sakuma, Kenji; Okuya, Makoto; Nomura, Ikuo; Iwata, Nakao Journal: Neuropsychopharmacology reports Issue: Volume 41:Issue 4(2021) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Factors associated with discontinuation in the drug and placebo groups of trials of second generation antipsychotics for acute schizophrenia: A meta-regression analysis: Discontinuation in antipsychotic trials. (November 2020) Authors: Kishi, Taro; Matsuda, Yuki; Sakuma, Kenji; Okuya, Makoto; Iwata, Nakao Journal: Journal of psychiatric research Issue: Volume 130(2020) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗